Hudson Bay Capital Management LP
Position in UTHR — UNITED THERAPEUTICS Corp
CIK 1393825
STAMFORD, CT
Position in UTHR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$12,403,955
+$3,380,880 QoQ
Shares Held
20,918
-2.8% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Jun 30, 2025CallValue
$7,183,750
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Hudson Bay Capital Management LP holds $123,784,198 across 12 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
395,850 | $52,149,278 | |
| 2 | BHC |
Bausch Health Companies Inc.
|
5,000,000 | $27,000,000 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
20,918 | $12,403,955 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
364,212 | $11,101,181 | |
| 5 | ALKS |
Alkermes plc.
|
173,626 | $6,139,415 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
90,821 | $4,694,536 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
490,369 | $4,668,312 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
151,366 | $3,142,358 |
All Filings in UTHR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,403,955 | 20,918 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $9,023,075 | 21,524 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $7,183,750 | 25,000 | Call | Sole | 2025-08-18 | |
| 2025-06-30 | $11,593,710 | 40,347 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $20,906,563 | 67,819 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $24,811,355 | 70,319 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,724,650 | 35,509 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $32,173,550 | 101,000 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $23,891,250 | 75,000 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $4,594,400 | 20,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,440,779 | 11,100 | Shares | Sole | 2024-02-14 | |
| 2020-12-31 | $1,517,900 | 10,000 | Shares | Sole | 2021-03-04 | |
| 2020-09-30 | $3,535,000 | 35,000 | Shares | Sole | 2020-11-12 | |
| 2020-03-31 | $6,638,100 | 70,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||